Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial

MICRO-ABSTRACT: In a Phase I dose-finding study of metronomic daily oral vinorelbine in advanced non-small-cell lung cancer, a recommended dose was established for this therapeutic approach. In addition, this trial revealed promising efficacy data and an acceptable tolerability profile. The observed...

Descripción completa

Detalles Bibliográficos
Autores principales: Guetz, Sylvia, Tufman, Amanda, von Pawel, Joachim, Rittmeyer, Achim, Borgmeier, Astrid, Ferré, Pierre, Edlich, Birgit, Huber, Rudolf Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328303/
https://www.ncbi.nlm.nih.gov/pubmed/28260922
http://dx.doi.org/10.2147/OTT.S122106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328303/
https://www.ncbi.nlm.nih.gov/pubmed/28260922
http://dx.doi.org/10.2147/OTT.S122106

Ejemplares similares